Qilu Pharmaceutical (Hainan) Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.273-A, Nanhai Avenue, National High-Tech Zone, Haikou, Hainan 570314, China (CHN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3008250362 · DUNS 529131725
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-05-19
- VAIDrug Quality Assurance2019-11-06
- NAIDrug Quality Assurance2017-11-17
- VAIDrug Quality Assurance2016-08-02
- VAIDrug Quality Assurance2014-05-23
Drugs this plant is listed as making
18 distinct drugs across 55 products name this site in their FDA label.
- BortezomibBluePoint Laboratories
- Bumetanidein shortageQilu Pharmaceutical Co., Ltd.
- DaptomycinQilu Pharmaceutical Co., Ltd.
- decitabineQilu Pharmaceutical Co., Ltd.
- Fosaprepitant DimeglumineQilu Pharmaceutical Co., Ltd.
- GefitinibQilu Pharmaceutical Co., Ltd.
- imatinib mesylateUpsher-Smith Laboratories, LLC
- Irinotecan HydrochlorideQilu Pharmaceutical Co., Ltd.
- melphalan hydrochlorideQilu Pharmaceutical Co., Ltd.
- MicafunginQilu Pharmaceutical Co., Ltd
- Nicardipine HydrochlorideQilu Pharmaceutical Co., Ltd.
- OndansetronApotex Corp.
- oxaliplatinApotex Corp.
- Palonosetron HydrochlorideQilu Pharmaceutical Co., Ltd.
- Pemetrexed disodiumBluePoint Laboratories
- TadalafilUpsher-Smith Laboratories, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.